Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling

被引:57
作者
Jenkins, Jean
Calzone, Kathleen A. [1 ]
Dimond, Eileen
Liewehr, David J.
Steinberg, Seth M.
Jourkiv, Oxana
Klein, Pam
Soballe, Peter W.
Prindiville, Sheila A.
Kirsch, Ilan R.
机构
[1] Natl Human Genome Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Genet Branch, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, Biostat & Data Management Sect, Bethesda, MD 20892 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[6] Amgen Inc, Seattle, WA USA
关键词
genetic testing; genetic counseling; BRCA1/BRCA2; result disclosure; risk communication;
D O I
10.1097/GIM.0b013e31812e6220
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. Methods: A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. Results: There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. Conclusions: These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 34 条
  • [1] [Anonymous], 1996, MEASURING HLTH
  • [2] GENETIC-COUNSELING FOR FAMILIES WITH INHERITED SUSCEPTIBILITY TO BREAST AND OVARIAN-CANCER
    BIESECKER, BB
    BOEHNKE, M
    CALZONE, K
    MARKEL, DS
    GARBER, JE
    COLLINS, FS
    WEBER, BL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (15): : 1970 - 1974
  • [3] Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2
    Bluman, LG
    Rimer, BK
    Berry, DA
    Borstelmann, N
    Iglehart, JD
    Regan, K
    Schildkraut, J
    Winer, EP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 1040 - 1046
  • [4] Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis
    Braithwaite, D
    Emery, J
    Walter, F
    Prevost, AT
    Sutton, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (02): : 122 - 133
  • [5] Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer
    Calzone, KA
    Prindiville, SA
    Jourkiv, O
    Jenkins, J
    DeCarvalho, M
    Wallerstedt, DB
    Liewehr, DJ
    Steinberg, SM
    Soballe, PW
    Lipkowitz, S
    Klein, P
    Kirsch, IR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3455 - 3464
  • [6] Calzone KA, 1997, CANCER PRACT, V5, P228
  • [7] Campbell L, 1997, BRIT J SURG, V84, P1381
  • [8] Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO
  • [9] 2-Z
  • [10] What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
    Coyne, JC
    Kruus, L
    Racioppo, M
    Calzone, KA
    Armstrong, K
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 116A (03): : 222 - 228